PRINCIPAL INVESTIGATOR:  Ronald M. Lawrence, M.D., Ph.D.

INSTITUTION:  Council for Natural Nutrition

INTRODUCTION:

A total of 21 patients were studied for 6 weeks for the hair study component. Data was collected by Certified Cosmetologists under the direction of the Principal Investigator. Both the investigators and the patients were blinded as to whether supplementation was with placebo or LIGNISULMSM. The subjects were randomly assigned to either Group A (placebo) or Group B (LIGNISULMSM).

Sixteen of the subjects were men and 5 were women. Dosage was 3,000 mg/day in both Groups A & B.

The study participants were studied for hair length, brilliance, and diameter of the individual hair fibers using industry standard measurement scales at the beginning of the study period (t=0) and after 6 weeks (t=6 weeks).

RESULTS & DISCUSSION:

Those subjects supplemented with LIGNISULMSM showed significant improvement in hair health, while those on placebo showed either no change, or only slight changes after 6 weeks.  The most marked changes were measured in hair length and hair brilliance. The women showed the better results in hair growth, brilliance, and thickness of hair fibers.

All subjects supplemented with LIGNISULMSM were duly impressed with the changes in the health and appearance of their hair.  The cosmetologists literally could differentiate which participants were on LIGNISULMSM by the appearance of the hair alone after 6 weeks.

It is expected that if the study were continued for 8 to 16 weeks, the results would have been even better for those on LIGNISULMSM as has been our past experience.

CONCLUSION:

This pilot double blind, random study proves that oral supplementation with LIGNISULMSM is a valuable addition to hair care. Hair health was significantly improved in a short term of 6 weeks.

INTRODUCTION:

A total of 11 patients were studied for 6 weeks for the nail study component. Data was collected by Certified Cosmetologists under the direction of the Principal Investigator. All investigators and the patients were blinded as to whether supplementation was with placebo or LIGNISULMSM. The subjects were randomly assigned to either Group A (placebo) or Group B (LIGNISULMSM).

Dosage was 3,000 mg/day in both Groups A & B.

The study participants’ nails were measured for length, thickness, luster and general appearance using industry standard measurement scales at the beginning of the study period (t=0) and after 6 weeks (t=6 weeks).

RESULTS & DISCUSSION:

Those subjects supplemented with LIGNISULMSM showed significant improvement in nail strength, thickness and appearance. Results would be better at periods of over 8 weeks from our clinical experience, but it was felt to be too difficult to keep clients enrolled in the study if it lasted longer than 6 weeks. This way we had no dropouts. Overall improvement rate was 80% even in this short study. All subjects supplemented with LIGNISULMSM stated they would continue to use LIGNISULMSM on an ongoing basis based on the improvement in nail health and appearance that was observed.

CONCLUSION:

This pilot double blind, random study proves that oral supplementation with LIGNISULMSM is a valuable addition to nail care. Nail health was significantly improved by 80% overall in a short term of 6 weeks.